Clinical Trials
5 trialsNCT02158858 2025-10-08
A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies
Constellation Pharmaceuticals
Phase 1/2 Completed
NCT06401356 2025-06-22
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
Novartis
Phase 3 Recruiting
NCT01949883 2024-05-08
A Phase 1 Study Evaluating CPI-0610 in Patients With Progressive Lymphoma
Constellation Pharmaceuticals
Phase 1 Completed
NCT02157636 2024-04-18
A Phase 1 Study Evaluating CPI-0610 in Patients With Previously Treated Multiple Myeloma
Constellation Pharmaceuticals
Phase 1 Completed
NCT02986919 2018-09-11
Study of CPI-0610 in Patients With Malignant Peripheral Nerve Sheath Tumors
University of Texas Southwestern Medical Center
Phase 2 Withdrawn